Published on 16 May 2023 on Insider Monkey via Yahoo Finance
Daré Bioscience, Inc. (NASDAQ:DARE) Q1 2023 Earnings Call Transcript
Daré Bioscience, Inc. (NASDAQ:DARE) Q1 2023 Earnings Call Transcript May 11, 2023
Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.1.
Operator: Welcome to the conference call hosted by Daré Bioscience to review the Company’s Financial Results for the Quarter Ended March 31, 2023, and to provide a General Business Update. This call is being recorded. My name is Mallory and I will be your operator today. With us today are Sabrina Martucci Johnson, Daré’s President and Chief Executive Officer; John Fair, Daré’s Chief Commercial Officer; and Lisa Walters-Hoffert, Daré’s Chief Financial Officer. Ms. Johnson, please proceed.